Cargando…

Securitization of pandemic risk by using coronabond

This article investigates the pandemic risk coverage within the European Union member states through insurance securitization. This strategy allows the transfer of health risks from the insurance market to the financial markets. We focus on the financial market crisis caused by the COVID-19 pandemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Haffar, Adlane, Le Fur, Éric, Khordj, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109232/
https://www.ncbi.nlm.nih.gov/pubmed/37362252
http://dx.doi.org/10.1007/s11408-023-00425-2
_version_ 1785027017722298368
author Haffar, Adlane
Le Fur, Éric
Khordj, Mohamed
author_facet Haffar, Adlane
Le Fur, Éric
Khordj, Mohamed
author_sort Haffar, Adlane
collection PubMed
description This article investigates the pandemic risk coverage within the European Union member states through insurance securitization. This strategy allows the transfer of health risks from the insurance market to the financial markets. We focus on the financial market crisis caused by the COVID-19 pandemic to securitize the losses caused by the latter. Over the period from 24/01/2020 (the first proven case of contamination in Europe) to 31/03/2020 (end of the dramatic decrease in financial markets), we apply the extreme value theory allowing the selection of the trigger threshold. We identify an immediate reaction of the financial markets following a pandemic shock, the effect of which fades after a few days. The response of stock market indices, measured by the fluctuation of return rates, is not very high. Nevertheless, the reaction of the financial markets is sufficient for the corona bond triggering, provided that the threshold for triggering the incidence rate is optimal. In addition, the securitization of insurance risk could be an alternative process to the classic risk transfer techniques such as co-insurance and reinsurance. Finally, a reinsurance pool dedicated to the insurance scheme's management against the effects of a pandemic is crucial for insurance securitization. These results could have implications for various actors such as insurers, financial investors, and States.
format Online
Article
Text
id pubmed-10109232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-101092322023-04-18 Securitization of pandemic risk by using coronabond Haffar, Adlane Le Fur, Éric Khordj, Mohamed Financ Mark Portf Mang Article This article investigates the pandemic risk coverage within the European Union member states through insurance securitization. This strategy allows the transfer of health risks from the insurance market to the financial markets. We focus on the financial market crisis caused by the COVID-19 pandemic to securitize the losses caused by the latter. Over the period from 24/01/2020 (the first proven case of contamination in Europe) to 31/03/2020 (end of the dramatic decrease in financial markets), we apply the extreme value theory allowing the selection of the trigger threshold. We identify an immediate reaction of the financial markets following a pandemic shock, the effect of which fades after a few days. The response of stock market indices, measured by the fluctuation of return rates, is not very high. Nevertheless, the reaction of the financial markets is sufficient for the corona bond triggering, provided that the threshold for triggering the incidence rate is optimal. In addition, the securitization of insurance risk could be an alternative process to the classic risk transfer techniques such as co-insurance and reinsurance. Finally, a reinsurance pool dedicated to the insurance scheme's management against the effects of a pandemic is crucial for insurance securitization. These results could have implications for various actors such as insurers, financial investors, and States. Springer US 2023-04-17 /pmc/articles/PMC10109232/ /pubmed/37362252 http://dx.doi.org/10.1007/s11408-023-00425-2 Text en © The Author(s) under exclusive licence to Swiss Society for Financial Market Research 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Haffar, Adlane
Le Fur, Éric
Khordj, Mohamed
Securitization of pandemic risk by using coronabond
title Securitization of pandemic risk by using coronabond
title_full Securitization of pandemic risk by using coronabond
title_fullStr Securitization of pandemic risk by using coronabond
title_full_unstemmed Securitization of pandemic risk by using coronabond
title_short Securitization of pandemic risk by using coronabond
title_sort securitization of pandemic risk by using coronabond
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109232/
https://www.ncbi.nlm.nih.gov/pubmed/37362252
http://dx.doi.org/10.1007/s11408-023-00425-2
work_keys_str_mv AT haffaradlane securitizationofpandemicriskbyusingcoronabond
AT lefureric securitizationofpandemicriskbyusingcoronabond
AT khordjmohamed securitizationofpandemicriskbyusingcoronabond